Hot Pursuit     17-Aug-23
Glenmark Pharma gets USFDA nod for Tacrolimus Ointment
Glenmark Pharmaceuticals said that it has received ANDA approval by US Food and Drug Administration (USFDA) for Tacrolimus Ointment.
Tacrolimus Ointment tacrolimus is used on the skin to treat a skin condition in patients who have not responded well to other eczema medications. It is equivalent to generic version of Protopic, Ointment, 0.03%, of Leo Pharma AS. Glenmark's Tacroli.

According to IQVIA sales data for the 12‐month period ending June 2023, the Protopic Ointment, 0.03% market achieved annual sales of approximately $15.4 million.

Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace and 51 ANDA's pending approval with the U.S. FDA.

Glenmark Pharmaceuticals reported 18% decline in net profit to Rs 173.1 crore in Q1 FY24 as compared with Rs 211.1 crore in Q1 FY23. Total revenue from operations jumped 22.48% to Rs 3,401.6 crore during the quarter as compared with Rs 2,777.3 crore posted in same quarter last year.

The scrip fell 1% to Rs 789.25 on the BSE.

Previous News
  Glenmark Pharmaceuticals launches TEVIMBRA® in India
 ( Corporate News - 24-Jun-25   10:53 )
  Nifty fails to hold 24,850 mark; media shares tumble
 ( Market Commentary - Mid-Session 18-Jun-25   11:36 )
  Glenmark pharma's US facility receives five observations after USFDA GMP inspection
 ( Hot Pursuit - 18-Jun-25   09:51 )
  Glenmark Pharmaceuticals Ltd soars 0.98%, rises for fifth straight session
 ( Hot Pursuit - 11-Jun-25   13:00 )
  Glenmark Pharma rises after zanubrutinib launch in India
 ( Hot Pursuit - 09-Jun-25   12:02 )
  Glenmark receives DCGI approval to launch oncology drug BRUKINSA in India
 ( Corporate News - 09-Jun-25   11:04 )
  Board of Glenmark Pharmaceuticals recommends final dividend
 ( Corporate News - 24-May-25   11:52 )
  Glenmark Pharmaceuticals reports consolidated net profit of Rs 4.65 crore in the March 2025 quarter
 ( Results - Announcements 24-May-25   07:44 )
  Glenmark Pharmaceuticals grants 1.19 lakh stock options under ESOS
 ( Corporate News - 22-May-25   16:03 )
  Glenmark Pharmaceuticals announces board meeting date
 ( Corporate News - 13-May-25   15:58 )
  Ichnos Glenmark Innovation receives USFDA fast track designation for ISB 2001
 ( Corporate News - 05-May-25   19:16 )
Other Stories
  ZEN Technologies ends higher after receiving patent for long-pass optical filter
  30-Jun-25   18:44
  Torrent Pharma gains after inking pact to acquire majority stake in JB Chemicals & Pharma
  30-Jun-25   16:02
  Suditi Industries jumps 17% in seven days
  30-Jun-25   15:23
  J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group
  30-Jun-25   15:00
  Aimtron Electronics gains on inking Rs 98-crore ODM contract with US Firm
  30-Jun-25   14:52
  Sigachi Industries Ltd leads losers in 'B' group
  30-Jun-25   14:45
  Sigachi Industries drops after deadly explosion at Telangana facility
  30-Jun-25   14:32
  Volumes soar at Alembic Pharmaceuticals Ltd counter
  30-Jun-25   14:30
  HEC Infra secures Rs 3-cr work order from Ahmedabad Municipal Corporation
  30-Jun-25   14:26
  Jindal Steel commissions first galvanizing line at Angul Complex
  30-Jun-25   13:40
Back Top